The Biosimilars Forum is a U.S.-based nonprofit trade group that represents makers and supporters of biosimilar medicines (drugs that are highly similar to existing biologic drugs). Its lobbying filings show it pushes on health and Medicare/Medicaid issues, including FDA rules for biosimilars, Medicare reimbursement, drug pricing legislation, and implementation of the Inflation Reduction Act to expand access to biosimilars. It hires Thorn Run Partners for lobbying.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
ALEX DELPIZZO
The latest disclosures for this client.
THORN RUN PARTNERS
Q1THORN RUN PARTNERS
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
THORN RUN PARTNERS
mrs THAYER SURETTE ROBERTS
THORN RUN PARTNERS
STUART CHAPMAN
THORN RUN PARTNERS
THORN RUN PARTNERS
Q3THORN RUN PARTNERS
Q2THORN RUN PARTNERS
Q1